XML 35 R25.htm IDEA: XBRL DOCUMENT v3.24.3
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING AND NON-RECURRING BASIS

The following table provides a summary of financial assets measured at fair value on a recurring basis as of September 30, 2024 and December 31, 2023 (in thousands):

 

Description  Fair Value at
September 30,
2024
   Level 1   Level 2   Level 3 
                 
Recurring Assets                    
Cash equivalents                    
Money market funds  $15,193   $15,193   $   $ 
Short-term investments                    
U.S. treasury securities   43,572    43,572         
U.S. federal agency securities   36,863        36,863     
Certificates of deposit   13,540    13,540         
Total assets measured at fair value  $109,168   $72,305   $36,863   $ 
                     
Liabilities                    
Payable to licensor  $4,921   $   $   $4,921 
Warrant liabilities   38,789            38,789 
Total liabilities measured at fair value   43,710   $   $    43,710 

 

 

Description  Fair Value at
December 31,
2023
   Level 1   Level 2   Level 3 
                 
Recurring Assets                    
Cash equivalents                    
Money market fund  $1,034   $1,034   $   $ 
Short-term investments                    
U.S. treasury securities   8,393    8,393         
U.S. federal agency securities   29,360        29,360     
Total assets measured at fair value  $38,787   $9,427   $29,360   $ 
                     
Liabilities                    
Payable to licensor  $4,580   $   $   $4,580 
Warrant liabilities   31,352            31,352 
Total liabilities measured at fair value  $35,932   $   $   $35,932 
SCHEDULE OF OUTSTANDING WARRANT LIABILITIES

As of September 30, 2024 and December 31, 2023, the Company had the following outstanding warrant liabilities:

 

   September 30, 2024   December 31, 2023 
Warrants issued as part of the 2021 public offering, expiration date December 2026, exercise price of $9.75 per share   1,788,000    1,788,000 
Warrants issued as part of the 2022 Private Placement Offering, expiration date November 2027, exercise price $4.75 per share   7,609,879    7,609,879 
Warrants issued as part of the 2024 Loan Agreement, expiration date January 2029, exercise price $4.07 per share   

589,681

    

 
SCHEDULE OF ACTIVITY OF WARRANT LIABILITIES

The following table provides a summary of the activity on the warrant liabilities (in thousands):

 

      
Warrant liabilities as of December 31, 2023  $31,352 
Fair value of warrants issued in connection with the Loan Agreement   220 
Loss recognized in earnings from change in fair value   7,217 
Warrant liabilities as of September 30, 2024  $38,789 
SCHEDULE OF ESTIMATE FAIR VALUE OF WARRANTS

The following table outlines the key inputs for the Black-Scholes option-pricing model:

 

   September 30, 2024   December 31, 2023 
         
Common share price   $6.32    $5.01 
Expected term (years)   2.214.27     2.963.84  
Risk-free interest rate (%)   3.51% – 3.57%    3.84% – 3.92% 
Volatility (%)   96.51% - 100.00%    100.00% 
Expected dividend yield (%)   0%    0% 
SCHEDULE OF ACTIVITY OF DERIVATIVE LIABILITIES

The following table provides a summary of the activity on the derivative liabilities (in thousands):

 

       
Derivative liabilities as of December 31, 2023  $  
Fair value of derivatives issued in connection with Loan Agreement   822 
Loss recognized in earnings from change in fair value   313 
Reclassification of derivative liability in connection with the Loan Agreement   (1,135)
Derivative liabilities as of September 30, 2024  $ 
SCHEDULE OF ESTIMATE FAIR VALUE OF DERIVATIVES

The following table outlines the key inputs for the Monte Carlo simulation model:

 

   September 30, 2024   December 31, 2023 
         
Common share price   $6.32     
Expected term (years)   2.75     
Risk-free interest rate (%)   3.53%    
Volatility (%)   93.79%